Presentation Summary : ... serological responses to current vaccines, and the availability of candidate vaccine strains and reagents Make recommendations for the strains of influenza A ...
Source : http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM343314.ppt
Presentation Summary : Vaccine storage and handling. Vaccines are fragile and must be kept at recom-mended temperatures at all times. Vaccines are expensive. It is better to NOT VACCINATE ...
Source : http://www.immunize.org/presentations/to-err-is-human.ppt
Presentation Summary : There are two types of flu vaccine: Flu shot which contains only pieces of killed flu viruses. Nasal spray which contains inactivated flu viruses.
Source : http://www.health.ny.gov/prevention/immunization/health_care_personnel/docs/influenza_vaccination_of_hcp.ppt
Presentation Summary : Reconstituted vaccine should be discarded at the end of each immunization session and NEVER retained for use in subsequent sessions.
Source : http://www.pitt.edu/~super7/32011-33001/32501.ppt
Presentation Summary : Safety of 2009 H1N1 Vaccine (cont.) Based on clinical trials, the 2009 H1N1 influenza vaccine has a similar safety profile as seasonal flu vaccines, ...
Source : http://www.jointcommission.org/assets/1/18/H1N1_ppt_slides.ppt
Presentation Summary : What is the Flu Vaccine? Seasonal vaccine. Protects against three strains. Adapted Yearly. The influenza vaccine offers protection against 3 strains of the flu the ...
Source : http://public.health.oregon.gov/PreventionWellness/VaccinesImmunization/ImmunizationProviderResources/Documents/AdultFluWebinar.pptx
Presentation Summary : * Vaccine effectiveness: Post licensure monitoring of VE Post-licensure: maintenance of VE Problems in vaccine delivery Cold chain failure, schedule violation, ...
Source : http://www.pitt.edu/~super7/43011-44001/43241-43251.ppt
Presentation Summary : Inactivated Influenza Vaccine (TIV) Fluzone® (sanofi pasteur) Only TIV currently approved for use in children younger than 48 months. Fluvirin® (Novartis)
Source : https://www.ndhealth.gov/EMS/pdfs/EMS%20Influenza%202009.ppsx
Presentation Summary : There is Nothing New Under the Sun Vaccines for bioterrorism agents pose the extreme cases of vaccine law and policy Consent versus Mandated Vaccinations Liability ...
Source : http://biotech.law.lsu.edu/blaw/bt/smallpox/balt_vaccine.ppt
Presentation Summary : Influenza Vaccine Manufacturing Industry perspective for 2013-2014 influenza vaccine supply The FDA CBER requested this annual summary of information from influenza ...
Source : http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM343332.ppt
Presentation Summary : An effective vaccine could have a MAJOR Impact on the future prognosis iavi.org This allows T cells to recognize HIV infected cells, for example, ...
Source : http://courses.bio.unc.edu/2010Fall/Biol062/powerpoints/AIDSvaccine.ppt
Presentation Summary : Immigration Medical Exams & Form I-693 USCIS Civil Surgeon Seminar Series June 12, 2012 * Frequently Asked Questions * Frequently Asked Questions Q: Can an applicant ...
Source : http://www.uscis.gov/sites/default/files/USCIS/Resources/Designated%20Civil%20Surgeons/4_CS_Training-Vaccinations_Session.ppt
Presentation Summary : Types of Vaccines. Types. Modified live vaccines (MLV) Killed inactivated vaccines. Withdrawal times. Use determined by. Disease. Species. Vaccine availability
Source : http://www.cfsph.iastate.edu/Emergency-Response/Just-in-Time/12-Vaccination-Overview_PPT.pptx
Presentation Summary : DNA vaccine for env/gag augmented with IL Challenge with SHIV 1 of 8 monkeys developed disease after 20 weeks Showed loss of CTL against a gag protein ...
Source : http://biology.fullerton.edu/biol426/13_vaccines1.PPT
Presentation Summary : Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002
Source : http://www.bt.cdc.gov/agent/smallpox/training/webcast/dec2002/files/contra-and-screening.ppt
Presentation Summary : Vaccines What’s that have to do with Biomedical Engineering? By: Jonathan Lloyd What is a Vaccine? A vaccine is an antigenic material that stimulate adaptive ...
Source : http://www.ele.uri.edu/courses/bme281/F11/JonathanL_1.ppt
Presentation Summary : Agenda--1 Overview & Introductions Flu Disease & Flu Vaccine Intramuscular Injection “Immunization Techniques” Video Skills practice 1: ...
Source : http://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Children-and-Disasters/Documents/H1N1-Immunization-Training.ppt
Presentation Summary : FDA/CBER Role in Smallpox Vaccine Safety Bob Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology CBER, FDA January 23, 2003
Source : http://www.bt.cdc.gov/agent/smallpox/training/aeworkshop/fda-cber-role.ppt
Presentation Summary : Reducing Vaccine Administration Errors. Susan Reeser, RN, BSN. Nurse Consultant. April 2013
Source : http://www.dphhs.mt.gov/publichealth/immunization/documents/ReducingVaccineAdministrationErrors.pptx
Presentation Summary : Additionally Kentucky Vaccine Program purchases . vaccines with state funds to cover: The Hepatitis B birth dose in the hospital, and. Medicaid Program
Source : http://chfs.ky.gov/NR/rdonlyres/F1804088-7585-4002-987D-A961BA72AA4F/0/VaccinesforChildrenUnderinsuredPatients.pptx
Presentation Summary : Smallpox Vaccine: Overview for Health Care Response Teams Thomas G. Franck, MD, MPH Regional Physician Consultant Office of Emergency Preparedness & Response
Source : http://www.vdh.state.va.us/oep/Powerpoint/SmallpoxHospitals.ppt